Total overall health and societal costs are
shown in Table 4. There is an advantage
(although with highly skewed confidence
limits) for the treatment period, with a difference
of UK £1086 in healthcare costs
and £1284 in societal costs in favour of
the therapy group, but costs are higher at
follow-up. The intervention dominates at
the post-treatment evaluation with both
lower costs and a greater proportion of
participants showing cognitive improvement
(mean difference 21%, 95% CI 0–41).